Renier J C, Bernat M, Rebel A, Jallet P
Rev Rhum Mal Osteoartic. 1976 Jul-Sep;43(7-9):481-9.
The levels of circulating 25 OH-D were determined by a direct radio-competition methods both in normal subjects and in subjects with various pathological conditions. In normal subjects, the average level of 25 OH-D was higher in summer (42.3 ng/ml) than in winter (29.1 ng/ml), P less than 0.005. Monthly variations in the 25 HO-D levels were found in relation to insolation The level of 25 OH-D was practically normal in osteoporosis (28.9 ng/ml), clearly lower in the mixed forms called "osteoporomalacia" (13.5 ng/ml, P less than 0.005) and very low in osteomalacia (5.8 ng/ml, P less than 0.001). In cases of cortisone osteopathy the average level was 22.8 ng/ml (NS). The level of 25 OH-D was also found to be lower in hepatic cirrhosis (11.7 ng/ml, P less than 0.01), in subjects treated with anticonvulsants (P less than 0.01), and in the course of hyperparathyroidism (P less than 0.002). There was no corelation between the level of 25 OH-D and calcaemia, phosphoraemia, circulating immunoreactive parathyroid hormone, or the relative osteoid volume. In contrast, there seemed to be a good correlation with the level of alkaline phosphatasaemia. The level of 25 OH-D was also determined in 4 subjects with vitamin-resistant osteomalacia: in 3 cases hepatic hydroxylation seemed normal, indicating the possibility of a subsequent disorder of vitamin D metabolism; in one case the absence of hepatic hydroxylation was noted.
采用直接放射竞争法测定了正常人和患有各种病理状况的受试者体内循环25-羟基维生素D(25 OH-D)的水平。在正常受试者中,25 OH-D的平均水平夏季(42.3 ng/ml)高于冬季(29.1 ng/ml),P<0.005。发现25-羟基维生素D(25 HO-D)水平存在与日照相关的月度变化。骨质疏松症患者的25 OH-D水平实际上正常(28.9 ng/ml),在称为“骨质疏松性骨软化症”的混合形式中明显较低(13.5 ng/ml,P<0.005),而在骨软化症中非常低(5.8 ng/ml,P<0.001)。在可的松性骨病病例中,平均水平为22.8 ng/ml(无显著性差异)。还发现肝硬化患者(11.7 ng/ml,P<0.01)、接受抗惊厥药治疗的受试者(P<0.01)以及甲状旁腺功能亢进过程中的受试者(P<0.002)体内25 OH-D水平较低。25 OH-D水平与血钙、血磷、循环免疫反应性甲状旁腺激素或相对类骨质体积之间无相关性。相反,它似乎与碱性磷酸酶血症水平有良好的相关性。还对4例维生素抵抗性骨软化症患者测定了25 OH-D水平:3例患者肝脏羟化似乎正常,表明可能随后存在维生素D代谢紊乱;1例患者肝脏羟化缺失。